Hypertension is when blood pressure (BP) is measured above the limits of what is considered normal. Almost all guidelines define hypertension as a systolic blood pressure (SBP) above 140 mmHg and a diastolic blood pressure (DBP) above 90 mmHg. Blood pressure should not be seen only as a numerical value that should be monitored and lowered when it rises. Blood pressure is an important vital sign that can provide important clues to the clinician about the patient's current condition. Long-term control of hypertension in individuals significantly reduces cardiovascular risk. In the case of hypertensive emergencies or urgent situations, antihypertensive treatment should be initiated after consideration of the approach to the recommendations. Recent observational studies suggest that pharmacologic treatment of acute and asymptomatic in-hospital BP elevations may not be beneficial and may even increase the risk of in-hospital and post-discharge complications. The patient's current clinical status and additional comorbidities should be evaluated, and attention should be paid to contraindications and drug dosage adjustments.
Hipertansiyon, kan basıncının normal sınırları aştığı bir durumdur, sistolik ve diastolik tansiyon 140 ve 90 mmHg'nin üzerindedir. Uzun süreli yüksek tansiyon kontrolü kalp ve damar riskini azaltırken, hastaneye konulan hastalarda akut kan basıncı artışı tartışmalı. Mevcut kılavuzlar hastanede belirtilmemiş kan basıncı artışlarını veya bunların teşhisini, yönetimini ve takiplerini ele almıyor. Son çalışmalar, farmakolojik tedavinin faydalı olmayabileceğini ve komplikasyon riskini artırabileceğini öne sürüyor. Toplumda hipertansiyonun tespiti ve tedavisi faydalıdır, ancak semptomatik ve kısa süreli kan basıncı artışlarının klinik önemi hakkında az şey bilinmektedir. Hastaneye konulan hastalarda akut yüksek tansiyonda her zaman antihipertansif tedavi gerektirmeyebilir, ancak güvenilir ölçüm protokolleri gereklidir.
Primary Language | English |
---|---|
Subjects | Internal Diseases |
Journal Section | Review [en] Derleme [tr] |
Authors | |
Publication Date | December 31, 2023 |
Submission Date | November 30, 2023 |
Acceptance Date | December 25, 2023 |
Published in Issue | Year 2023 Volume: 4 Issue: 6 |
TR DİZİN ULAKBİM and International Indexes (1d)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.
EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation.
Journal articles are evaluated as "Double-Blind Peer Review".